Platforms

Oryzon has a long tradition to collaborate with the pharma and agrofood industry in their innovative processes.
We can offer a wide range of services including

• Genomics: including gene expression, copy number variation, and differential splicing analysis.
• Bioinformatics: including mode of action studies.
• Development of accompanying markers for in vivo efficacy studies.
• Target validation.
• Development of new biochemical or cellular assays including cell panel testing.
• B2D2 Platform: including fragment-screening, crystallography and molecular modeling.

Our internal need for results of the highest quality for our programs in diagnostics and drug developmentn and an ISO9001 quality system is the best guarantee for the quality of our services.